Parties have signed a Joint Development Agreement to create an RNAi-based, environmentally friendly biopesticide for an important agricultural pest

Vancouver, Canada and Utrecht, Netherlands — November 2, 2023 — Renaissance BioScience, a leader in bioengineering microbes for the global agriculture and food industries, is pleased to announce that it has signed a joint development agreement (JDA) with Certis Belchim, a global leader in the development of crop-protecting biocontrol agents that combat agricultural pests. Under the JDA, the two industry leaders will collaboratively harness Renaissance’s innovative yeast-based RNA interference (RNAi) platform technology to develop and commercialize an environmentally friendly biopesticide against an, as yet, unspecified target pest. This revolutionary technology holds immense promise for addressing agricultural challenges through its targeted approach. This partnership speaks to the companies’ shared commitment to advancing eco-friendly alternatives in pest management.

Dr. John Husnik, Renaissance’s CSO and Office of the CEO, commented on the JDA: “Certis Belchim is a world leader in crop protection and biocontrol innovation and technologies, and we are delighted to be working with them to develop an effective and environmentally safe yeast-based RNAi biopesticide.”

Mr. Jan Mostert, Head of Biorational Projects of Certis Belchim, commented: “Certis Belchim have committed and pursued innovative solutions for sustainable agriculture.  The Renaissance RNA interference technology is highly innovative and will deliver products which come close to the idea of an ideal plant protection product in being very specific and very effective at the same time while also reconciling the often-contradicting goals of crop protection, and protecting the environment and biodiversity.  We believe this project could potentially contribute to reinforce our biorational platform, that is one of the strategic pillars for Certis Belchim. We are enthusiastic about working closely with Renaissance, a highly skilled and agile company, on this exciting biorational technology initiative.”

About Certis Belchim BV

Certis Belchim, created through the merger of Certis Europe B.V. and Belchim Crop Protection NV/SA in 2022, provides a new force in crop protection. The company combines the strengths of these two well-established businesses with expertise in product development, registration and marketing and best-in-class technical and product knowledge. It has strong foundations and an established footprint throughout Europe, dynamic and growing platforms in North America and expanding opportunities with partners in Africa, South America and Asia. More information about Certis Belchim is available at www.certisbelchim.com.

 

About Renaissance BioScience Corp.

Based in Vancouver, Canada, Renaissance is a leading bioengineering company whose platform technologies are used to develop innovative, market-ready, functional microorganisms that provide cost-effective solutions to address a broad range of environmental, health and industrial efficiency challenges. Renaissance technologies create products for multiple end-use industries, including food & beverage, agriculture, animal and human health and energy. Detailed information about the Renaissance group of companies is available at www.renaissancebioscience.com.

For further information or to arrange interviews, please contact: 

Steve Campbell

Campbell & Company Strategies Inc.

Communications and Public Relations

Vancouver, BC CANADA

01 604 888-5267

renaissance@ccom-pr.com

For commercial or technology development inquiries please contact:

Reesha Parmar

Manager of Business Development and Strategy

rparmar@renaissancebioscience.com

Caution Regarding Forward-Looking Statements

This press release may include forward-looking statements with respect to the Company based on management’s opinions, estimates and assumptions considering its experience and perception of historical trends, current conditions and expected future developments, as well as other factors that management currently believes are appropriate and reasonable in the circumstances. Generally, forward-looking statements can be identified using terminology such as “anticipate”, “will”, “expect”, “may”, “continue”, “could”, “estimate”, “forecast”, “plan”, “potential” and similar expressions. The forward-looking statements contained in this press release are made as of the date hereof.  

Forward-looking statements contained in this press release may include, but are not limited to: statements with respect to the successful execution of the Company's business and investment strategy (including its business model), the Company’s intellectual property, entrance of the Company’s business into new markets, the use and benefits of its products and services, the Company’s favourable position in the market on a go-forward basis, demographic and market size/trends, forecasts of revenue and financial projections/growth potential, competitive analysis, projected milestones, go-forward management, go-forward capitalization, anticipated governmental and regulatory approvals and other expectations, beliefs, plans, objectives, assumptions, intentions or statements about future events or performance, review and approval dates, start-up timelines and schedules and statements related to the continued overall advancement of the Company’s business.  

By their nature, forward-looking statements are subject to a variety of factors that could cause actual results to differ materially from the results suggested by the forward-looking statements. In addition, the forward-looking statements require the Company to make assumptions and are subject to inherent risks and uncertainties. Despite a careful process to prepare and review the forward-looking information, there can be no assurance that the underlying opinions, estimates and assumptions will prove to be correct. There is significant risk that the forward-looking statements will not prove to be accurate, that the Company’s assumptions may not be correct and that actual results may differ materially from such forward-looking statements. Accordingly, readers should not place undue reliance on the forward-looking statements. 

Except as required by law, the Company undertakes no obligation to update publicly or to revise any forward-looking statements that are contained or incorporated in this press release. All forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

 

Back to all news